Amendment No. 18 to the Restated License Agreement, dated November 1, 1994, by and between Standard & Poors Financial Services LLC (as successor-in-interest to Standard & Poors, a division of McGraw-Hill, Inc.) and Cboe Exchange, Inc. (f/k/a Chicago Board Options Exchange, Incorporated), made as of October 26, 2021
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[*confidential treatment requested*]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
Exhibit 10.1
Amendment No. 18
to
License Agreement dated as of November 1, 1994
by and between S&P Dow Jones Indices, LLC (“S&P”)
and
Choe Exchange, Inc. (“CBOE”)
(formerly Chicago Board Options Exchange, Incorporated)
as previously amended (the “1994 Agreement”)
AND
Amendment No. 4
to
Amended and Restated License Agreement dated as of September 29, 2006
by and between DJI Opco, LLC (“DJI Opco”)
and
CBOE
as previously amended (the “2006 Agreement”)
This Amendment (this “Amendment”) is made as of October 26, 2021 (the “Amendment Effective Date”) and, with respect to the 1994 Agreement, is by and between S&P and CBOE, and, with respect to the 2006 Agreement, is by and between DJI Opco and CBOE (DJI Opco being a wholly owned subsidiary of S&P, and the successor by assignment to Dow Jones & Company, Inc., the original party with CBOE to the 2006 Agreement).
WHEREAS, the 1994 Agreement as in effect prior to the date of this Amendment consists of: the License Agreement effective as of November 1, 1994 as subsequently amended by Amendment No. 1 effective January 15, 1995, Amendment No. 2 effective April 1, 1998, Amendment No. 3 effective July 28, 2000, Amendment No. 4 effective October 27, 2000, Amendment No. 5 effective March 1, 2003, Amended and Restated Amendment No. 6 effective February 24, 2009 (which implemented Addendum No. 1), Amended and Restated Amendment No. 7 effective February 24, 2009, Amendment No. 8 effective January 9, 2005, Amendment No. 10 effective June 19, 2009, Amendment No. 11 effective April 29, 2010, Amendment No. 12 effective March 8, 2013, Amendment No. 13 effective December 21, 2017, Amendment No. 14 effective January 1, 2017, Amendment No. 15 effective January 15, 2019, Amendment No. 16 effective April 1, 2020 and Amendment No. 17 effective August 1, 2020 (Amendment No. 9 effective April 23, 2007 having been terminated as of February 24, 2009);
WHEREAS, the 2006 Agreement as in effect prior to the date hereof consists of: the License Agreement dated as of September 29, 2006 as amended by Amendment No. 1 made as of August 22, 2011, Amendment No. 2 made as of December 21, 2017 and Amendment No. 3 made as of April 1, 2020; and
WHEREAS, the parties now desire to amend the 1994 Agreement and the 2006 Agreement as set forth in this Amendment.
NOW THEREFORE, the parties agree as follows:
Page 1 of 4
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[*confidential treatment requested*]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
(h)“Mini-SPX Contract” shall mean, with respect to the S&P 500 Index, the S&P 500 ESG Index or any of the Select Sector Indices, a Standardized Option Contract that is based on reduced values of such index that are calculated by multiplying the values of such index as published by S&P by a decimal value equal to 0.1.
(z)“Nano-SPX Contract” shall mean, with respect to the S&P 500 Index, a Standardized Option Contract that is based on reduced values of such index that are calculated by multiplying the values of such index as published by S&P by a decimal value equal to 0.001.
(i)Subject to the Annual Minimum and Annual Maximum provisions set forth in Addendum No. 3 to this Agreement (“Addendum No. 3”), a fee for each cleared S&P 500 Contract traded on the market of CBOE or any Affiliate of CBOE as reflected in the records of the clearing agency utilized by CBOE or any Affiliate of CBOE to clear trades in such Contracts at the rate of: (1) $[*confidential treatment requested*] per cleared Nano-SPX Contract; (2) $[*confidential treatment requested*] per cleared Mini-SPX Contract; and (3) $[*confidential treatment requested*] per Contract for all other cleared S&P 500 Contracts during calendar year 2013 from the Amendment No. 12 Effective Date, $[*confidential treatment requested*] per Contract for all other cleared S&P 500 Contracts during calendar year 2014, $[*confidential treatment requested*] per Contract for all other cleared S&P 500 Contracts during calendar years 2015 through 2022, and $[*confidential treatment requested*] for all other cleared S&P 500 Contracts during the remaining term of this Agreement; provided however notwithstanding the foregoing, where CBOE or an Affiliate of CBOE has rebated transaction fees for closing trades in S&P 500 Contracts executed for purposes of reducing holdings and corresponding capital requirements and such trades result in no transaction fees to CBOE (“Compression Trades”), such as in a compression forum as described in CBOE Rule 6.56, up to an annual cap of two hundred thousand dollars ($200,000) of per Contract fees (or such higher amount as may be approved in writing by S&P in its sole discretion) otherwise payable pursuant to this Paragraph 5(a)(i) for such Compression Trades executed during calendar year 2017 and each year thereafter during the term of this Agreement are hereby waived. At S&P’s option, S&P may terminate the foregoing fee waiver set forth in this Section 5(a)(i) upon written notice to CBOE with effect at any time as of January 1, 2025 forward during the Term. In addition, S&P may terminate the foregoing fee waiver at any time during the Term upon written notice to CBOE if applicable laws, rules or regulations change such that the benefit of Compression Trades is eliminated. In addition to CBOE’s reporting requirements set forth in this Agreement, within thirty days after the end of each calendar quarter, CBOE shall report to S&P both the number of Nano-SPX Contracts traded along with the net transaction fees received by CBOE and its Affiliates with respect to the Nano-SPX Contracts for the immediately preceding quarter. After the three (3) year anniversary of listing Nano-SPX Contracts for trading, S&P DJI may provide notice of its interest in increasing the per Contract rate for the Nano-SPX Contracts and the parties shall review and negotiate an appropriate rate in good faith.
Page 2 of 4
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[*confidential treatment requested*]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
Page 3 of 4
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[*confidential treatment requested*]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.
The terms and conditions of this Amendment are acknowledged and agreed to:
CBOE EXCHANGE, INC. | S&P DOW JONES INDICES, LLC | ||
| |||
Signature: | /s/ John Deters | Signature: | /s/ Bruce Schachne |
Name: | John Deters | Name: | Bruce Schachne |
Title: | EVP, Chief Strategy Officer | Title: | Chief Commercial Officer |
Date: | Oct 27, 2021 | Date: | Oct 27, 2021 |
DJI OPCO, LLC | |||
Signature: | /s/ Bruce Schachne | ||
Name: | Bruce Schachne | ||
Title: | Chief Commercial Officer | ||
Date: | Oct 27, 2021 |
Page 4 of 4